Listen to The Lancet Oncology
de The Lancet Oncology
In conversation with... James Nagarajah
Sobre este podcast
The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
Episodios
Los 20 episodios más recientes de 222
- In conversation with... James Nagarajah · 11 minCheryl Reeves, Senior Editor at The Lancet Oncology, is joined by Professor James Nagarajah to discuss his open-label, randomised, phase 2 study [177Lu]-PSMA-617-PSMA-617 in…
- In conversation with... Ali Landman · 15 minJoin us for this special episode where Deputy Editor Cheryl Lai speaks with Ali Landman, Editor-in-Chief of The Lancet Medical Imaging & Theranostics, about the scope and vision…
- In conversation with... Kayleigh Bhangdia · 18 minKayleigh Bhangdia discusses the latest GBD breast cancer study data, telling the audience about epidemiological trends, disease burden, and risk factors associated with breast…
- In conversation with... Dylan Graetz and Erica Kaye · 42 minJamie Prowse, Senior Editor at The Lancet Oncology, is joined by Dr Dylan Graetz and Dr Erica Kaye to discuss qualitative in oncology.
- In conversation with... Jesse Plascak and Marissa Baker · 23 minCheryl Lai, Senior Editor of The Lancet Oncology, is joined by Dr Jesse Plascak and Dr Marissa Baker to discuss their population-based study analysing cancer mortality rates by…
- In conversation with... Andre Pfob and Peter Dubsky · 26 minDr Andre Pfob and Prof Peter Dubsky discuss their Review entitled The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early…
- In conversation with... Gary Rodin · 11 minDr Gary Rodin discusses The human crisis in cancer: a Lancet Oncology Commission which identifies a growing imbalance between technological innovation and the human dimensions of…
- In conversation with... Matthias Preusser · 17 minDeputy Editor Ali Landman speaks with Matthias Preusser about two reports from the phase 2 TUXEDO-3 trial investigating patritumab deruxtecan (HER3-Dxd) in patients with active…
- In conversation with... Andrea Necchi · 12 minAndrea Necchi, Associate Professor at the Vita-Salute San Raffaele University, discusses his SunRISe4-trial published in our October issue.
- In conversation with... Linda Bi, Ruchit Patel, Chloe Gui, Farshad Nassiri, & Matija Snuderl · 14 minKat Gourd, Acting Deputy Editor of The Lancet Oncology, is joined by Dr Linda Bi, Dr Ruchit Patel, Dr Chloe Gui, Dr Farshad Nassiri, and Dr Matija Snuderl, from institutions in…
- In conversation with... Jinming Li · 8 minJinming Li discusses his international, multicohort, observational study on patterns in genomic mutations among patients with early-onset colorectal cancer.
- In conversation with... Caroline Robert · 11 minSmriti Patodia, Senior Editor of The Lancet Oncology, is joined by Professor Caroline Robert from Gustave Roussy Cancer Campus, France to discuss the EBIN trial on the use of a…
- In conversation with... Richard Bryant · 18 minKat Gourd, Acting Deputy Editor of The Lancet Oncology, is joined by Professor Richard Bryant from the University of Oxford to discuss the TRANSLATE trial on transperineal vs…
- In conversation with... Amar U. Kishan · 8 minProfessor Amar U. Kishan (Department of Radiation Oncology, University of California, Los Angeles, CA, USA) discusses his paper on HYpofractionateD RAdiotherapy for Prostate…
- In conversation with... Ariana Znaor on cancer surveillance · 20 minAriana Znaor (Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France) discusses her Review on cancer surveillance in the Eastern Mediterranean…
- In conversation with... Yannick Romero · 25 minDr Yannick Romero (Union for International Cancer Control) discusses his Policy Review on the changing landscape of the national cancer control plans and his work with the…
- In conversation with... Steven Horwitz · 15 minDr Steven Horwitz (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses a phase 1 study of valemetostat in relapsed or refractory non-Hodgkin lymphoma and a phase…
- In conversation with... May Abdel-Wahab and Andrew Scott · 41 minMay Abdel-Wahab (Division of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria) and Andrew Scott (Department of…
- In conversation with... Zachary Zumsteg · 17 minDr Zachary Zumsteg (Cedars-Sinai Medical Center, Los Angeles, CA, USA) discusses his Review on the challenges and opportunities for early phase clinical trials of novel…
- In conversation with... Kanwal Raghav · 13 minDr Kanwal Raghav (Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA) discusses his Article entitled…








